Asthma: Management

Crofton and Douglas's Respiratory Diseases: Fifth Edition

Volumn 2, Issue , 2008, Pages 973-997

  Crompton, Graham ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Asthma; Bronchodilator; Management; Morbidity; Peak flow monitoring

Indexed keywords

EID: 5644265781     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470695999.ch35     Document Type: Chapter

References (313)

1. British Thoracic Society. The British guidelines on asthma management: 1995 review and position statement. Thorax 1997; 52 (Suppl 1): S1.
2. Hilton S, Sibbald B, Anderson MR, Freeling P. Controlled evaluation of the effects of patient education on morbidity in general practice. Lancet 1986; i: 26.
3. Jenkinson D, Davison J, Jones S, Martin P. Comparison of effects of a self management booklet and audio cassette for patients with asthma. Br Med J 1988; 297: 267.
4. Bernard-Bonian AC, Stachenko S, Bonin D, Chasette C, Rousseau E. Self management teaching programs and morbidity of paediatric asthma: a meta-analysis. J Allergy Clin Immunol 1995; 95: 34.
5. Lindgren B. The importance of selfmanagement. Eur Respir Rev 1996; 6: 108.
6. Osman L, Adalla M, Beattie J et al. Reducing hospital admission through computer supported education for asthma patients. Br Med J 1994; 308: 568.
7. Lloyd BW, Ali MH. How useful do parents find home peak flow monitoring for children with asthma? Br Med J 1992; 305: 1128.
8. Kendrick AH, Higgs CMB, Whitfield MJ, Laslo G. Accuracy of perception of severity of asthma: patients treated in general practice. Br Med J 1993; 307: 422.
9. Crompton GK, Grant IWB, Bloomfield P. Edinburgh Emergency Asthma Admission Service: report on 10 years' experience. Br Med J 1979; ii: 1199.
10. Fireman P, Friday GA, Gira C, Veirthaler WA, Michaels L. Teaching self management skills to asthmatic children and their parents in an ambulatory care setting. Pediatrics 1981; 68: 341.
11. Beasley R, Cushley M, Holgate ST. Aself management plan in the treatment of adult asthma. Thorax 1989; 44: 200.
12. Hayward SA, Levy M. Self management of asthma. Br J Gen Pract 1990; 40: 166.
13. Charlton I, Charlton G, Broomfield J, Mullee MA. Evaluation of peak flow and symptoms only self management plans for control of asthma in general practice. Br Med J 1990; 301: 1355.
14. Kolbe J, Vamos M, Fergusson W, Elkind G, Garrett J. Differential influences on asthma self-management knowledge and selfmanagement behavior in acute severe asthma. Chest 1996; 110: 1463.
15. Brewis RAL. Patient education, self management plans and peak flow measurements. Respir Med 1991; 85: 457.
16. Partridge MR. Asthma: guided self management. Br Med J 1994; 308: 547.
17. Cochrane GM. Therapeutic compliance in asthma: its magnitude and implications. Eur Respir J 1992; 5: 122.
18. Cochrane GM. Compliance in asthma: a European perspective. Eur Respir Rev 1995; 5: 116.
19. Wright BM, McKerrow CB. Maximum forced expiratory flow rate as a measure of ventilatory capacity with a description of a new portable instrument for measuring it. Br Med J 1959; ii: 1041.
20. Sly PD, Landau LI, Weymouth R. Home recording of peak expiratory flow rates and perception of asthma. Am J Dis Child 1985; 139: 479.
21. von Mutius E, Fritzsch C, Weiland SK, Röll G, Magnussen H. Prevalence of asthma and allergic disorders among children in united Germany: a descriptive comparison. Br Med J 1992; 305: 1395.
22. Sears MR, Hervison GP, Holdaway MD, Hewitt CJ, Flannery EM, Silva PA. The relative risks of sensitivity to grass pollen, house dust mite, and cat dander in the development of childhood asthma. Clin Exp Allergy 1989; 19: 419.
23. Sporik R, Holgate S, Platts-Mills TAE, Cogswell J. Exposure to house dust mite allergen (Der p1) and the development of asthma in childhood. N Engl J Med 1990; 323:502.
24. Holt P, McMenamin C, Nelson D. Primary sensitisation to inhalant allergens during infancy. Pediatr Allergy Immunol 1990; 1: 3.
25. Arshad SH, Matthews S, Grant C, Hide DW. Effect of allergen avoidance on development of allergic disorders in infancy. Lancet 1992; 339: 1493.
26. Sloper KS, Wadsworth J, Brostoff J. Children with atopic eczema. 1. Clinical response to food elimination and subsequent doubleblind food challenge. Q J Med 1991; 80: 677.
27. Chapman MD, Hayman PW, Wilkins R, Brown MB, Platts-Mills TAE. Monoclonal immunoassays for the major dust mite (Dermatophagoides) allergens Der p1 and Der f1 and quantitative analysis of the allergen content of mite and house dust extracts. J Allergy Clin Immunol 1987; 80: 184.
28. Luczynska CM, Li Y, Chapman MD, Platts-Mills TAE. Airborne concentrations and particle size distribution of allergen derived from domestic cats (Felis domesticus):measurement using cascade impactor, liquid impinger and two site monoclonal antibody assay for Fel d1. Am Rev Resp Dis 1990; 141: 361.
29. Munir AKM, Einarsson R, Schou C, Dreborg SKG. Allergens in school dust. J Allergy Clin Immunol 1993; 91: 1067.
30. Coren S. Allergic patients do not comply with doctors' advice to stop owning pets. Br Med J 1997; 314: 517.
31. Crompton GK. How I manage the difficult asthmatic. Proc R Coll Physicians Edinb 1997; 27: 194.
32. Collof MJ, Ayers J, Carswell F et al. The control of allergens of dust mites and domestic pets: a position paper. Clin Exp Allergy 1992; 22 (Suppl 2): 1.
33. Owen S, Morgenstern M, Hepworth J, Woodcock A. Control of house dust mite antigen in bedding. Lancet 1990; 335: 396.
34. Walshaw MJ, Evans CC. Allergen avoidance in house dust mite sensitive adult asthma. Q J Med 1986; 58: 199.
35. Dorward AJ, Colloff MJ, Mackay NS, McSharry C, Thomson NC. Effect of house dust mite avoidance measures in adult atopic asthma. Thorax 1988; 43: 98.
36. Ehnert B, Lau-Schadendorf S, Weber A, Buettner P, Schou C, Wahn V. Reducing domestic exposure to dust mite allergen reduces bronchial hyperreactivity in sensitive children with asthma. J Allergy Clin Immunol 1993; 90: 135.
37. Murray AB, Fergusson AC. Dust free bedroom in the treatment of asthmatic children with house dust mite allergy: a controlled trial. Pediatrics 1983; 91: 418.
38. Wood RA, Mudd KE, Eggleston PA. The distribution of cat allergen on vertical surfaces. J Allergy Clin Immunol 1990; 85: 226.
39. de Blay F, Chapman MD, Platts-Mills TAE. Airborne cat levels (Fel d1). Environmental control with the cat in situ. Am Rev Respir Dis 1991; 143: 1334.
40. Mawhinney H, Spector SL, Kinsman RA et al. Compliance in clinical trials of two nonbronchodilator, antiasthma medications. Ann Allergy 1991; 66: 294.
41. Rand CS, Wise RA, Nides M et al. Metereddose adherence in a clinical trial. Am Rev Respir Dis 1992; 146: 1559.
42. Bosley CM, Parry DT, Cochrane GM. Patient compliance with inhaled medication: does combining beta-agonists with corticosteroids improve compliance? Eur Respir J 1994; 7: 504.
43. Horn CR, Clark TJH, Cochrane GM. Compliance with inhaled therapy and morbidity from asthma. Respir Med 1990; 84: 66.
44. British Thoracic Association. Death from asthma in two regions of England. Br Med J 1982; 285: 1251.
45. Cochrane GM. Compliance in asthma: a European perspective. Eur Respir Rev 1995; 26: 116.
46. Blackwell B, Gutmann MC. Compliance. In:Bulpitt CJ, ed. Handbook of Hypertension, Vol 6, Epidemiology of Hypertension. Amsterdam:Elsevier Science Publishers, 1985, p. 35.
47. Hilton S, Sibbald B, Anderson JR, Freeling P. Controlled evaluation of the effects of patients' education on asthma morbidity in general practice. Lancet 1986; i: 26.
48. Pretet S, Perdrizet S, Poisson N, Pujet JCM, Marsac J. Treatment compliance and selfmedication in France. Eur Respir J 1989; 2:303.
49. Kraan J, Koëter GH, van der Mark TW, Sluiter HJ, de Vries K. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with anti-asthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. J Allergy Clin Immunol 1985; 76: 628.
50. Vathenen AS, Knox AJ, Higgins BG, Britton JR, Tattersfield AE. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet 1988; i:554.
51. Kerrebijn KF, Essen-Zandvliet EEM, Neijens HJ. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol 1987; 79:653.
52. van Schayck CP, Graafsma SJ, Visch MB, Dompeling E, van Weel C, van Herwaarden CLA. Increased bronchial hyperresponsiveness after inhaling salbutamol during one year is not caused by subsensitisation to salbutamol. J Allergy Clin Immunol 1990; 86:793.
53. Sears MR, Taylor DR, Print CG et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990; 336: 1391.
54. van Schayck CP, Dompeling E, van Herwaarden CLA. Bronchodilator treatment in moderate asthma or chronic bronchitis:continuous or demand. Arandomised control trial. Br Med J 1991; 303: 1426.
55. National Heart, Lung and Blood Institute, National Institutes of Health. International Consensus Report on Diagnosis and Management of Asthma. Eur Respir J 1992; 5: 601.
56. Pearce N, Grainger M, Crane J et al. Casecontrol study of prescribed fenoterol and death from asthma in New Zealand, 1977-1981. Thorax 1990; 45: 170.
57. Spitzer WO, Suisa S, Ernst P et al. The use of beta-agonists and the risk of death and neardeath from asthma. N Engl J Med 1992; 326:501.
58. Löfdahl C-G, Svedmyr N. Beta-agonists:friends or foes? Eur Respir J 1991; 4: 1161.
59. Ernst P, Habbick B, Suisa S et al. Is the association between inhaled beta-agonists and life-threatening asthma because of confounding by severity. Am Rev Respir Dis 1992; 148: 75.
60. Tattersfield AE, Britton JR. b2-Adrenoreceptor agonists. In: Barnes PJ, Rodger IW, Thomson NC, eds. Asthma: Basic Mechanisms and Clinical Management. London: Academic Press, 1992: 527.
61. Jenne JW. Bronchodilators. In: O'Byrne P, Thomson NC, eds. Manual of Asthma Management. London: WB Saunders, 1995: 291.
62. Nials AT, Sumner MT, Johnson M, Coleman RA. Investigation into factors determining the duration of action of the b2-adrenoreceptor agonist, salmeterol. Br J Pharmacol 1993; 108: 507.
63. National Asthma Education Program. Asthma Management Handbook. Melbourne:National Asthma Campaign, 1993.
64. Ulman A, Svedmyr N. Salmeterol, a new long acting inhaled b2-adrenoreceptor agonist: a comparison with salbutamol in adult asthmatic patients. Thorax 1988; 43:674.
65. Dahl R, Earnshaw JS, Palmer JBD. Salmeterol:a four week study of a long-acting beta-adrenoreceptor agonist for the treatment of reversible airways disease. Eur Respir J 1991; 4: 1178.
66. Palmer JBD. Salmeterol in clinical practice. Eur Respir J 1991; 4: 297.
67. Britton MG, Earnshaw JS, Palmer JBD. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. Eur Respir J 1992; 5: 1062.
68. Pearlman DS, Chervinsky P, LaForce C et al. Acomparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N Engl J Med 1992; 327: 1420.
69. Palmer JBD, Stuart AM, Shepherd GL, Viskum K. Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease: a 3 month comparison of the efficacy and safety of twice daily salmeterol (100μg) with salmeterol (50μg). Respir Med 1992; 86: 409.
70. Jack D. Away of looking at agonism and antagonism: lessons from albuterol, salmeterol, and other b-adrenoreceptor agonists. Br J Clin Pharmacol 1991; 31: 501.
71. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994; 344: 219.
72. Meijer RJ, Kerstjens HAM, Postma DS. Comparison of guidelines and selfmanagement plans in asthma. Eur Respir J 1997; 10: 1163.
73. Lipworth BJ, McDevitt DG, Struthers AD. Systemic b-adrenoreceptor responses to salbutamol given by metered-dose inhaler alone and with pear shaped spacer attachment:comparison of electrocardiographic, hypokalaemic and haemodynamic effects. Br J Clin Pharmacol 1989; 27: 837.
74. Lipworth BJ, Tregaskis BF, McDevitt DG. b-Adrenoreceptor responses to inhaled salbutamol in the elderly. Br J Clin Pharmacol 1989; 28: 725.
75. Kendall MJ, Haffner C. The acute unwanted effects of beta2 receptor agonist therapy. In:Beasly R, Pearce NE, eds. The Role of Beta Receptor Agonist Therapy in Asthma Mortality. Boca Raton, Florida: CRC Press, 1993: 163.
76. Jenne JW, Ridley DF, Marcucci R, Druz WS, Rook JC. Objective and subjective tremor responses to oral beta-2 agents on first exposure. Am Rev Respir Dis 1982; 126: 607.
77. Jenne JW. Physiology and pharmacodynamics of theophylline. In: Jenne JW, Murphy S, eds. Drug Therapy for Asthma:Research and Clinical Practice. New York:Marcel Dekker, 1987: 297.
78. Jenne JW, Wyse E, Rood BS, MacDonald FM. The pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline. Clin Pharmacol Ther 1972; 13: 349.
79. Hendeles L, Weinberger M, Johnson G. Monitoring serum theophylline levels. Clin Pharmacokinet 1978; 3: 294.
80. Racineux JL, Troussier J, Tureant A. Comparison of bronchodilator effects of salbutamol and theophylline. Bull Eur Physiopathol Respir 1981; 17: 799.
81. Wolfe JD, Tashkin DP, Calvarese B, Simmons M. Bronchodilating effects of terbutaline and aminophylline alone and in combination in asthmatic patients. N Engl J Med 1978; 298: 363.
82. Billing B, Dahlquist R, Gal M. Separate and combined use of terbutaline and theophylline in asthmatics. Eur J Respir Dis 1982; 63: 399.
83. Svedmyr K, Svedmyr N. Does theophylline potentiate inhaled b2-agonists? Allergy 1982; 37: 101.
84. Aubier M, de Troyer A, Sampson M, Macklem PT, Roussos C. Aminophylline improves diaphragmatic contractility. N Engl J Med 1981; 305: 249.
85. Murciano D, Aubier M, Lecocguic Y, Pariente R. Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease. N Engl J Med 1984; 311: 349.
86. Calhoun WJ, Stevens CA, Lambert SB. Modulation of superoxide production of alveolar macrophages and peripheral blood mononuclear cells by beta-agonists and theophylline. J Lab Clin Med 1991; 117: 514.
87. Dent G, Giembycz MA, Rabe KF. Theophylline suppresses human alveolar macrophage respiratory burst through phosphodiesterase inhibition. Am J Respir Cell Mol Biol 1994; 10: 565.
88. Limatibul S, Shore A, Dosch HM, Gelfand EW. Theophylline modulation of E-rosette formation: an indicator of T-cell maturation. Clin Exp Immunol 1978; 33: 503.
89. Bruserud O. The effect of theophylline on Tlymphocyte activation in vitro. Clin Immunol Immunopathol 1984; 32: 111.
90. Sullivan PJ, Bekir S, Jaffar Z, Page CP, Costello JF. Anti-inflammatory effects of low dose oral theophylline in atopic asthma. Lancet 1995; 343: 1006.
91. Venge P, Dahl R, Karlstrom R, Pedersen B, Peterson CGB. Eosinophil activity in asthma in a one year double-blind trial with theophylline and two doses of inhaled budesonide. J Allergy Clin Immunol 1992; 89: 181.
92. Pauwels R, van Renterghem D, van der Straeten M, Johannesson N, Persson CGA. The effect of theophylline and enprofylline on allergen-induced bronchoconstriction. J Allergy Clin Immunol 1985; 76: 583.
93. Crescioli S, Spinazzi A, Plebani M et al. Theophylline inhibits early and late asthmatic reactions induced by allergens. Ann Allergy 1991; 66: 245.
94. Hendeles L, Harman E, Huang D et al. Alteration of allergen induced airways hyperactivity and late responses by theophylline. Eur Respir J 1991; 4: 481.
95. Hendeles L, Harman E, Huang D, O'Brien R, Blake K, Delafuente J. Theophylline attenuation of airways responses to allergen: comparison with cromolyn metered dose inhaler. J Allergy Clin Immunol 1995; 95: 505.
96. Matthys H, Muller S, Herceg R. Theophylline versus budesonide in the treatment of mild to moderate asthma. Respiration 1994; 61: 241.
97. Tinkleman DG, Reed CE, Nelson KS, Offord KP. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 1993; 92: 64.
98. Ruffin RE, Kitzgerald JD, Rebuck AS. A comparison of the bronchodilator activity of Sch 1000 and salbutamol. J Allergy Clin Immunol 1977; 59: 136.
99. Ullah MI, Newman GB, Saunders KB. Influence of age on response to ipratropium and salbutamol in asthma. Thorax 1981; 36: 523.
100. van Schayck CP, Folgering H, Harbers H, Maas KL, van Weel C. Effect of allergy and age on responses to salbutamol and ipratropium bromide in moderate asthma and chronic bronchitis. Thorax 1991; 46: 355.
101. Howell JBL, Altounyan REC. Adoubleblind trial of disodium cromoglycate in the treatment of allergic bronchial asthma. Lancet 1967; ii: 539.
102. Smith JM, Devey GF. Clinical trial of disodium cromoglycate in treatment of asthma in children. Br Med J 1968; ii: 340.
103. Shioda H, Murano J, Mishima K, Iikura Y, Tanaka F, Izeki M. Disodium cromoglycate (Intal) in the treatment of bronchial asthma in children. Acta Allergol 1970; 25: 221.
104. Engstrom I, Kraepelien S. The corticosteroid sparing effect of disodium cromoglycate in children and adolescents with bronchial asthma. Acta Allergol 1971; 26: 90.
105. Brompton Hospital/Medical Research Council Collaborative Trial. Long-term study of disodium cromoglycate in treatment of severe extrinsic or intrinsic bronchial asthma in adults. Br Med J 1972; iv:383.
106. Silverman M, Connolly NM, Balfour-Lynn L, Godfrey S. Long-term trial of disodium cromoglycate and isoprenaline in children with asthma. Br Med J 1972; 3: 378.
107. Northern General Hospital, Bromptom Hospital and Medical Research Council Collaborative Trial. Sodium cromoglycate in chronic asthma. Br Med J 1976; i: 361.
108. Eigen H, Reid JJ, Dahl R et al. Evaluation of the addition of cromolyn sodium to bronchodilator maintenance therapy in the longterm management of asthma. J Allergy Clin Immunol 1987; 80: 612.
109. Smith JM, Pizzarro YA. Observations on the safety of disodium cromoglycate in longterm use in children. Clin Allergy 1972; 2:143.
110. Hiller EJ, Milner AD. Betamethasone 17 valerate aerosol and disodium cromoglycate in severe childhood asthma. Br J Dis Chest 1975; 69: 103.
111. Mitchell I, Paterson IC, Cameron SJ, Grant IWB. Treatment of childhood asthma with sodium cromoglycate and beclomethasone dipropionate aerosol singly and in combination. Br Med J 1976; ii: 457.
112. Shapiro GG, Sharpe M, de Rouen TA et al. Cromolyn versus triamcinalone acetonide for youngsters with moderate asthma. J Allergy Clin Immunol 1991; 88: 742.
113. Ng SH, Dash CH, Savage SJ. Betamethasone valerate compared with sodium cromoglycate in asthmatic children. Postgrad Med J 1977; 53: 315.
114. Francis RS, McEnery G. Disodium cromoglycate compared with beclomethasone dipropionate in juvenile asthma. Clin Allergy 1984; 14: 537.
115. Silverman M, Andrea T. Time course of effect of disodium cromoglycate on exerciseinduced asthma. Arch Dis Child 1972; 47: 419.
116. Bar-Yishay E, Gur I, Levy M et al. Duration of action of disodium cromoglycate on exercise- induced asthma: comparison of 2 formulations. Arch Dis Child 1983; 58: 624.
117. Rohr AS, Siegel SC, Katz RM et al. Acomparison of inhaled albuterol and cromolyn in the prophylaxis of exercise-induced bronchospasm. Ann Allergy 1987; 59: 107.
118. Godfrey S, Balfour-Lynn L, König P. The place of cromolyn sodium in the long-term management of childhood asthma based on a 3-5 year follow-up. J Pediatr 1975; 87: 465.
119. Østergaard PA, Pedersen S. The effect of inhaled disodium cromoglycate and budesonide on bronchial responsiveness to histamine and exercise in asthmatic children. In:Godfrey S, ed. Glucocorticosteroids in Childhood Asthma. Amsterdam: Exerpta Medica, 1987: 55.
120. Brogden RN, Sorkin EM. Nedocromil sodium. An updated view of its pharmacological properties and therapeutic efficacy in asthma. Drugs 1993; 45: 693.
121. Konig P, Hordvik NL, Kreutz C. The preventative effect and duration of action of nedocromil sodium and cromolyn on exercise-induced asthma (EIA) in adults. J Allergy Clin Immunol 1987; 79: 64.
122. North American Tilade Study Group. A double-blind multicentre group comparative study of nedocromil sodium in the management of asthma. Chest 1990; 97: 1299.
123. Rebuck AS, Kesten S, Boulet LP et al. A3- month evaluation of the efficacy of nedocromil sodium in asthma: a randomized, double-blind, placebo-controlled trial of nedocromil sodium conducted by a Canadian multicentre study group. J Allergy Clin Immunol 1990; 85: 612.
124. Bone MF, Kubik MM, Keaney NP et al. Nedocromil sodium in adults with asthma dependent on inhaled corticosteroids: a double blind, placebo controlled study. Thorax 1989; 44: 654.
125. Boulet LP, Cartier A, Cockcroft DW et al. Tolerance to reduction of oral steroid dosage in severely asthmatic patients receiving nedocromil sodium. Respir Med 1990; 84:317.
126. Cartier A. Anti-allergic drugs. In: O'Byrne P, Thomson NC, eds. Manual of Asthma Management. London: WB Saunders, 1995: 254.
127. Lal S, Dorow PD, Venho KK, Chatterjee SS. Nedocromil sodium is more effective than cromolyn sodium for the treatment of chronic reversible obstructive airways disease. Chest 1993; 104: 438.
128. Boldy DA, Ayres JG. Nedocromil sodium and sodium cromoglycate in patients aged over 50 years with asthma. Respir Med 1993; 87: 517.
129. Rafferty P, Holgate ST. Anti-allergic drugs. In: Barnes PJ, Rodger IW, Thomson NC, eds. Asthma: Basic Mechanisms and Clinical Management. London: Academic Press, 1992:519.
130. Report to the Medical Research Council by the Subcommittee on Clinical Trials in Asthma. Controlled trial of effects of cortisone acetate in chronic asthma. Lancet 1956; i: 798.
131. Fletcher CM. The use of corticosteroids in the treatment of asthma and related conditions. Postgrad Med J 1958; 34: 310.
132. Brown HM, Storey G, George WS. Beclomethasone dipropionate: a new steroid aerosol for the treatment of allergic asthma. Br Med J 1971; i: 585.
133. Clark TJH. Effect of beclomethasone dipropionate delivered by aerosol in patients with asthma. Lancet 1972; i: 1361.
134. Cameron SJ, Cooper EJ, Crompton GK, Hoare MV, Grant IWB. Substitution of beclomethasone aerosol for oral prednisolone in the treatment of chronic asthma. Br Med J 1973; iv: 205.
135. Hodson ME, Batten JC, Clarke SW, Gregg I. Beclomethasone dipropionate aerosol in asthma. Transfer of steroid-dependent asthmatic patients from oral prednisolone to beclomethasone dipropionate aerosol. Am Rev Respir Dis 1974; 110: 403.
136. British Thoracic and Tuberculosis Association. Acontrolled trial of inhaled corticosteroids in patients receiving prednisolone tablets for asthma. Br J Dis Chest 1976; 70: 95.
137. Brogden RN. Inhaled steroids: studies in adult and childhood asthma. In: Clark TJH, ed. Steroids in Asthma: a Reappraisal in the Light of Inhalation Therapy. Auckland: ADIS Press, 1983: 135.
138. Latinen LA, Latinen A, Haahtela T. Acomparative study of the effects of an inhaled corticosteroid, budesonide, and of a b2- agonist, terbutaline, on airway inflammation in newly diagnosed asthma. J Allergy Clin Immunol 1992; 90: 32.
139. Djukanovic R, Wilson JW, Britten YM. Effect of an inhaled corticosteroid on airway inflammation and symptoms of asthma. Am Rev Respir Dis 1992; 145: 669.
140. Jeffery PK, Godfrey RW, Ädelroth E et al. Effect of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. Am Rev Respir Dis 1992; 145: 890.
141. Ädelroth E, Rosenhall L, Johansson S-Å, Linden M, Venge P. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. Am Rev Respir Dis 1990; 142: 91.
142. Cockroft DW, Murdoch KY. Comparative effects of inhaled salbutamol, sodium cromoglycate and BDP on allergen-induced early asthmatic responses, late asthmatic responses and increased bronchial responsiveness to histamine. J Allergy Clin Immunol 1987; 79: 734.
143. De Baets FM, Goetyn M, Kerrebijn KF. The effect of two months treatment with inhaled budesonide on bronchial responsiveness to histamine and house-dust mite antigen in asthmatic children. Am Rev Respir Dis 1990; 142: 581.
144. Henrikssen JM, Dahl R. Effects of inhaled budesonide alone and in combination with low-dose terbutaline in children with exercise induced asthma. Am Rev Respir Dis 1983; 128: 993.
145. Molema J, van Herwaarden CLA, Folgering HTM. Effect of long-term treatment with inhaled cromoglycate and budesonide on bronchial hyperresponsiveness in children with allergic asthma. Eur Respir J 1989; 2:308.
146. Kerrebijn KF, van Essen-Zandvliet EEM, Neijens HL. Effect of long-term treatment with inhaled corticosteroids and betaagonists on bronchial responsiveness in asthmatic children. J Allergy Clin Immunol 1987; 79: 653.
147. Dutoit JI, Salome CM, Woolcock AJ. Inhaled corticosteroids reduce the severity of bronchial hyperresponsiveness in asthma, but oral theophylline does not. Am Rev Respir Dis 1987; 136: 1174.
148. Juniper EF, Kline PA, van Zieleshem MA et al. Long-term effects of budesonide on airway responsiveness and clinical asthma severity in inhaled steroid-dependent asthmatics. Eur Respir J 1990; 3: 1122.
149. Haahtela T, Jarvinen M, Kava T et al. Comparison of a b2-agonist terbutaline with an inhaled steroid in newly detected asthma. N Engl J Med 1991; 325: 388.
150. Groot CAR, Lammers J-WJ, Festen J, van Herwaarden CLA. Effect of inhaled beclomethasone and nedocromil sodium on bronchial hyperresponsiveness to histamine and distilled water. Eur Respir J 1992; 5:1075.
151. Haahtela T, Järvinen M, Kava T et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994; 331: 700.
152. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994; 88: 373.
153. Selroos O, Pietinahlo A, Löfroos A-B, Riska H. Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest 1995; 108: 1228.
154. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis 1993; 148: S1.
155. Lorenzon S, Boe J, Eriksson G, Persson G. Use of inhaled corticosteroids in mild asthma. Thorax 1990; 45: 733.
156. Jones AH, Langdon CG, Lee PS et al. Pulmicort ® Turbohaler® once daily as initial prophylactic therapy for asthma. Respir Med 1994; 88: 293.
157. Hargreave FE, Dolovich J, Newhouse MT. The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol 1990; 85: 1098.
158. Toogood JH. High dose inhaled steroid therapy for asthma. J Allergy Clin Immunol 1989; 83: 528.
159. Laursen LC, Taudorf E, Weeke B. High-dose budesonide in treatment of severe steroiddependent asthma. Eur J Respir Dis 1986; 68:19.
160. Salmeron S, Guerin J-C, Godard P et al. High doses of inhaled corticosteroids in unstable chronic asthma. Am Rev Respir Dis 1989; 140:167.
161. Lacronique J, Renon D, Georges D, Henry-Amar M, Marsac J. High-dose beclomethasone:oral steroid-sparing effect in severe asthmatic patients. Eur Respir J 1991; 4: 807.
162. Hummel S, Lehtonen L. Comparison of oral steroid sparing by high-dose and low-dose inhaled steroid in maintenance treatment of severe asthma. Lancet 1992; 340: 1483.
163. Kraan J, Koeter GH, Van de Mark TW, Sluiter HJ, De Vries K. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. J Allergy Clin Immunol 1985; 76: 628.
164. Vathenen AS, Knox AJ, Wisniewski A, Tattersfield AE. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma. Am Rev Respir Dis 1991; 143: 1317.
165. Juniper EF, Kline PA, Vanzielegmem MA, Hargreave FE. Reduction of budesonide after a year of increased use: a randomised controlled trial to evaluate whether improvements in airways responsiveness are maintained. J Allergy Clin Immunol 1991; 87: 483.
166. Brown JP, Greville WH, Finucane KE. Asthma and irreversible airflow obstruction. Thorax 1984; 39: 131.
167. Peat JK, Woolcock AJ, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987; 70: 171.
168. Dompeling E, van Schayck CP, Molema J et al. Inhaled beclomethasone improves the course of asthma and COPD. Eur Respir J 1992; 5: 945.
169. Ernst P, Spitzer WD, Suissa S et al. Risk of fatal and near fatal asthma in relation to inhaled corticosteroid use. JAMA 1992; 268:3462.
170. Carmichael J, Paterson IC, Diaz P, Cromptom GK, Kay AB, Grant IWB. Corticosteroid resistance in chronic asthma. Br Med J 1981; 282: 1419.
171. Brown PH, Teelucksingh S, Matusiewicz SP, Greening AP, Crompton GK, Edwards CRW. Cutaneous vasoconstrictor responses to glucocorticoids in asthma. Lancet 1991; 337: 576.
172. Barnes PJ, Greening AP, Crompton GK. Glucocorticoid resistance in asthma. Am J Respir Crit Care Med 1995; 152: S125.
173. Milne JR, Crompton GK. Beclomethasone dipropionate and oropharyngeal candidiasis. Br Med J 1974; 3: 797.
174. Willey RF, Milne JR, Crompton GK, Grant IWB. Beclomethasone dipropionate aerosol and oropharyngeal candidiasis. Br J Dis Chest 1976; 70: 32.
175. Davis G, Thomas P, Broder I et al. Steroiddependent asthma treated with inhaled beclomethasone dipropionate. Along-term study. Ann Intern Med 1977; 86: 549.
176. Brompton Hospital/Medical Research Council Collaborative Trial. Double-blind trial comparing two dose schedules of beclomethasone dipropionate in the treatment of chronic bronchial asthma. Lancet 1974; ii: 303.
177. Toogood JH, Jennings B, Greenway RW, Chung L. Candidiasis and dysphonia complicating beclomethasone treatment of asthma. J Allergy Clin Immunol 1980; 65: 145.
178. Brogden RN, Heel RC, Speight TM, Avery GS. Beclomethasone dipropionate. Areappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis. Drugs 1984; 28:99.
179. Brogden RN, McTavish D. Budesonide. An updated review of its pharmacological properties and therapeutic efficacy in asthma and rhinitis. Drugs 1992; 44: 375.
180. Toogood JH, Jennings B, Baskerville J, Andersson J, Johansson SA. Dosing regimen of budesonide and occurrence of oropharyngeal complications. Am Rev Respir Dis 1989; 140: 624.
181. Smith MJ, Hodson ME. High-dose beclomethosone inhaler in the treatment of asthma. Lancet 1983; i: 265.
182. Toogood JH, Baskerville J, Jennings B. Use of spacers to facilitate inhaled corticosteroid treatment of asthma. Am Rev Respir Dis 1984; 129: 723.
183. Salzman GA, Mszczynski DR. Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with Aerochamber. J Allergy Clin Immunol 1988; 81: 424.
184. Spector SL, Wangaard C, Bardana EJ. The use of cultures and immunological procedures to predict oropharyngeal candidiasis in patients on steroid aerosols. Clin Allergy 1982; 12: 269.
185. Crompton GK. Local adverse effects of inhaled corticosteroids: oropharyngeal candidiasis and dysphonia. Prescribers' J 1995; 35: 59.
186. Sievert W, Holmes P, King RWF. Oesophageal candidosis in patients on highdose inhaled steroids. Lancet 1992; 339: 1551.
187. Williamson I, Matusiewicz S, Brown PH, Greening AP, Crompton GK. Frequency of voice problems and cough in patients using pressurized aerosol inhaled steroid preparations. Eur Respir J 1995; 8: 590.
188. Williams AJ, Baghat MS, Stableforth DE, Cryton RM, Shenos PM, Skinner C. Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality. Thorax 1983; 38: 813.
189. Settipane GA, Kalliel DE, Klein DE. Rechallenge of patients who developed oral candidiasis or hoarseness with beclomethasone dipropionate. N Engl Reg Allergy Proc 1987; 8: 95.
190. Selroos SO, Backman R, Forsen K-O et al. Local side-effects during 4 years treatment with inhaled corticosteroids: a comparison between metered dose inhaler and Turbuhaler. Allergy 1994; 49: 888.
191. Dewar MH, Matusiewicz SP, Ning A et al. Comparison of pMDI plus Nebuhaler' and Turbuhaler' in asthmatic patients with dysphonia. Thorax 1996; 51 (Suppl 3): A74.
192. Shim CS, Williams MH. Cough and wheezing from beclomethasone dipropionate aerosol are absent after triamcinolone acetonide. Ann Intern Med 1987; 106: 700.
193. Engel T, Heinig JH, Malling H-J, Scharing B, Nikander K, Masden F. Clinical comparison of inhaled budesonide delivered either by pressurized metered dose inhaler or Turbuhaler. Allergy 1989; 44: 220.
194. Yarbrough J, Lyndon RN, Mansfield E, Ting S. Metered dose inhaler induced bronchospasm in asthmatic patients. Ann Allergy 1985; 55: 25.
195. Crompton GK. Inhaled beclomethasone dipropionate in allergic bronchopulmonary aspergillosis. Report to Research Committee of British Thoracic Association. Br J Dis Chest 1979; 73: 349.
196. Seaton A, Seaton RA, Wightman AJA. Management of allergic bronchopulmonary aspergillosis without maintenance oral corticosteroids:a fifteen-year follow-up. Q J Med 1994; 87: 529.
197. Lundgren R, Söderberg M, Horstedt P, Stenling R. Morphological studies on bronchial mucosal biopsies from asthmatics before and after ten years treatment with inhaled steroids. Eur Respir J 1988; 1: 883.
198. Law CM, Preece MA, Warner JO. Nocturnal adrenal suppression in children inhaling beclomethasone dipropionate. Lancet 1986; i:321.
199. Harding SM, Daniel M. The clinical pharmacology of fluticasone propionate. Eur Respir J 1990; 3 (Suppl 10): 250S.
200. Szefler S. Glucocorticoid therapy for asthma: clinical pharmacology. J Allergy Clin Immunol 1991; 88: 147.
201. Geddes DM. Inhaled corticosteroids: benefits and risks. Thorax 1992; 47: 404.
202. Rogers DF, Ganderton D. Workshop report. Determining equivalence of inhaled medications. Respir Med 1995; 89: 253.
203. Fuller RW, Hallett C, Dahl R. Assessing equivalence of inhaled drugs. Respir Med 1995; 89: 525.
204. Maberly DJ, Gibson GJ, Butler AG. Recovery of adrenal function after substitution of beclomethasone dipropionate for oral corticosteroids. Br Med J 1973; i: 778.
205. Tarlo SM, Broder I, Davies GM, Lenzoff A, Minz S, Corey PN. Six month double-blind controlled trial of high dose, concentrated beclomethasone dipropionate in the treatment of severe chronic asthma. Chest 1988; 93: 998.
206. Stiksa G, Nemcek K, Glennow C. Adrenal function in asthmatics treated with highdose budesonide. Respiration 1985; 48: 91.
207. Luengo M, Picado C, Del Rio L, Gunabens N, Montserrat JM, Setoain J. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax 1991; 46: 803.
208. Wolthers O, Pedersen S. Growth of asthmatic children during treatment with budesonide: a double blind trial. Br Med J 1991; 303: 163.
209. Wolthers O, Pedersen S. Acontrolled study of linear growth in asthmatic children during treatment with inhaled glucocorticosteroids. Pediatrics 1992; 89: 839.
210. Wolthers O, Pedersen S. Growth in asthmatic children treated with budesonide. Pediatrics 1993; 90: 517.
211. Wolthers O, Pedersen S. Short term linear growth in asthmatic children during treatment with prednisolone. Br Med J 1990; 301:145.
212. Webb J, Clark TJH. Recovery of plasma corticotrophin and cortisol levels after a threeweek course of prednisolone. Thorax 1981; 36: 22.
213. Benatar SR. Fatal asthma. N Engl J Med 1986; 314: 423.
214. Eason SR, Markowe HLJ. Controlled investigation of deaths from asthma in hospitals in the North East Thames Region. Br Med J 1987; 294: 1255.
215. Wagner PD, Dantzker DR, Iacovoni VE, Tomlin WC, West JB. Ventilation-perfusion inequality in asymptomatic asthma. Am Rev Respir Dis 1978; 118: 511.
216. Ingram RH, Krumpe PE, Duffell GM, Maniscalco B. Ventilation-perfusion changes after aerolised isoproterenol in asthma. Am Rev Respir Dis 1970; 101: 364.
217. O'Driscoll BR, Cochrane GM. Emergency use of bronchodilator drugs in British hospitals. Thorax 1987; 42: 491.
218. Fitchett DH, McNicol MW, Riordan JF. Intravenous salbutamol in the management of status asthmaticus. Br Med J 1975; i: 53.
219. Bloomfield P, Carmichael J, Petrie GR et al. Comparison of salbutamol given intravenously and by intermittent positive pressure breathing in life-threatening asthma. Br Med J 1979; i: 848.
220. Swedish Society of Chest Medicine. High dose inhaled versus intravenous salbutamol compared with theophylline in severe acute asthma. Amulticentre study of 176 patients. Eur Respir J 1990; 3: 163.
221. Cheong B, Reynolds SR, Rajan G, Ward MJ. Intravenous beta agonist in severe acute asthma. Br Med J 1988; 297: 448.
222. Browne GJ, Penna AS, Phung X, Michael S. Randomised trial of intravenous salbutamol in the early management of acute severe asthma in children. Lancet 1997; 349: 301.
223. Kelly HW, McWilliams B, Katz R, Crowley M, Murphy S. Safety of frequent high dose nebulized terbutaline in children with acute asthma. Ann Allergy 1990; 64: 229.
224. Douglas JG, Rafferty P, Fergusson RJ et al. Nebulised salbutamol without oxygen in severe acute asthma: how effective and how safe? Thorax 1985; 40: 180.
225. Fergusson RJ, Carmichael J, Rafferty P et al. Nebulised salbutamol in life-threatening asthma: is IPPB necessary? Br J Dis Chest 1983; 77: 255.
226. Morgan MDL, Singh BV, Frame MH, Williams SJ. Terbutaline aerosol given through pear spacer in acute severe asthma. Br Med J 1982; 285: 849.
227. Ward MJ, Fentem PH, Roderick Smith WH, Davies D. Ipratropium bromide in acute asthma. Br Med J 1981; i: 589.
228. Leahy BC, Gomm SA, Allen SC. Comparison of nebulised salbutamol with nebulised ipratropium bromide in acute asthma. Br J Dis Chest 1983; 77: 159.
229. Rebuck AS, Chapman KR, Abboud R et al. Nebulised anticholinergic and sympathomimetic treatment of obstructive airways disease in the emergency room. Am J Med 1987; 82: 59.
230. Watson WT, Becker AB, Simons FE. Comparison of ipratropium solution, fenoterol solution, and their combination administered by nebulizer and face mask to children with acute asthma. J Allergy Clin Immunol 1988; 82: 1012.
231. O'Driscoll BR, Taylor RJ, Horsby MG, Chambers DK, Bernstein A. Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction. Lancet 1989; ii: 1418.
232. Higgins RM, Stradling JR, Lane DJ. Should ipratropium bromide be added to betaagonists in treatment of severe asthma? Chest 1988; 94: 718.
233. Summers QA, Tarala RA. Nebulised ipratropium in the treatment of acute asthma. Chest 1990; 97: 430.
234. Karpel JP, Schacter EN, Fanta C et al. Acomparison of ipratropium and albuterol vs albuterol alone for treatment of acute asthma. Chest 1996; 110: 611.
235. Whyte KF, Gould GA, Jeffrey AA, Airlie MA, Flenley DC, Douglas NJ. Dose of nebulized ipratropium bromide in acute severe asthma. Respir Med 1991; 85: 517.
236. Bordley JE, Carey RA, Harvey AMet al. Preliminary observations on the effect of adreno-corticotrophic hormone (ACTH) in allergic diseases. Bull Johns Hopkins Hosp 1949; 85: 396.
237. Medical Research Council. Controlled trial of effects of cortisone acetate in status asthmaticus. Lancet 1956; ii: 803.
238. Luksza AR. Acute severe asthma treated without steroids. Br J Dis Chest 1982; 76: 15.
239. Anon. Acute asthma. Lancet 1986; i: 131.
240. Fanta CH, Rossing TH, McFadden ER. Glucocorticoids in acute asthma: a critical controlled trial. Am J Med 1983; 74: 845.
241. Britton MG, Collins JV, Brown D et al. Highdose corticosteroids in severe acute asthma. Br Med J 1976; ii: 73.
242. Tanaka RM, Santiago SM, Kuhn GJ et al. Intravenous methylprednisolone in adults in status asthmaticus. Chest 1982; 82: 438-40.
243. Shee CD. Risk factors for hydrocortisone myopathy in acute severe asthma. Respir Med 1990; 84: 229.
244. Collins JV, Clark TJH, Brown D, Townsend J. Intravenous corticoids in the treatment of acute bronchial asthma. Lancet 1970; ii: 1047.
245. Harrison BDW, Stokes TC, Hart GJ et al. Need for intravenous hydrocortisone in addition to oral prednisolone in patients admitted to hospital with severe asthma without ventilatory failure. Lancet 1986; i:181.
246. Darioli R, Perret C. Mechanical controlled hypoventilation in status asthmaticus. Am Rev Respir Dis 1984; 129: 385.
247. Karetzky MS. Asthma mortality: an analysis of one year's experience, review of the literature and assessment of current modes of therapy. Medicine 1975; 54: 471.
248. Branthwaite MA. The management of severe asthma. In: Baderman H, ed. Management of Medical Emergencies. Tonbridge Wells: Pitman Medical, 1978: 48.
249. Higgins B, Greening AP, Crompton GK. Assisted ventilation in severe acute asthma. Thorax 1986; 41: 464.
250. Luksza AR, Smith P, Coakley J et al. Acute severe asthma treated by mechanical ventilation:10 years' experience from a district general hospital. Thorax 1986; 42: 459.
251. Greaser JB, Rowe AH. Inhalation of epinephrine for relief of asthmatic symptoms. J Allergy 1935; 6: 415.
252. Newman SP, Morén F, Pavia D, Sheahan NF, Clarke SW. Deposition of pressurised aerosols in the human respiratory tract. Thorax 1981; 36: 52.
253. Melchor R, Biddiscome MF, Mak VHF, Short MD, Spiro SG. Lung deposition patterns of directly labeled salbutamol in normal subjects and in patients with reversible airflow obstruction. Thorax 1993; 48: 506.
254. Newman SP, Pavia D, Clarke SW. How should a pressurized b-adrenergic bronchodilator be inhaled? Eur J Respir Dis 1981; 62: 3.
255. Paterson IC, Crompton GK. Use of pressurised aerosols by asthmatic patients. Br Med J 1976; i: 76.
256. Orehek J, Gayrard P, Grimaud CH, Charpin J. Patient error in use of bronchodilator metered aerosols. Br Med J 1976; i: 76.
257. Epstein SW, Manning CPR, Ashley MJ, Corey PN. Survey of the clinical use of pressurized aerosol inhalers. Can Med Assoc J 1979; 120: 813.
258. Gayrard P, Orehek J. Inadequate use of pressurized aerosols by asthmatic patients. Respiration 1980; 40: 47.
259. Crompton GK. Problems patients have using pressurized aerosol inhalers. Eur J Respir Dis 1982; 63 (Suppl 119): 101.
260. Crompton GK. Delivery systems. In:O'Byrne PM, Thomson NC, eds. Manual of Asthma Management. London: WB Saunders, 1995: 341.
261. Newman SP. Metered dose pressurized aerosols and the ozone layer. Eur Respir J 1990; 3: 495.
262. Morén F. Drug deposition of pressurized inhalation aerosols. 1. Influence of actuator tube design. Int J Pharm 1978; 1: 205.
263. Lindgren SB, Formgren H, Morén F. Improved aerosol therapy of asthma: effect of actuator tube size on drug availability. Eur J Respir Dis 1980; 61: 56.
264. Newman SP, Morén F, Pavia D, Little F, Clark SW. Deposition of pressurized suspension aerosols inhaled through extension devices. Am Rev Respir Dis 1981; 124: 318.
265. Tobin MJ, Jenouri G, Danta I, Kim C, Watson H, Sackner MA. Response to bronchodilator drug administration by a new reservoir aerosol delivery system and a review of other auxiliary delivery systems. Am Rev Respir Dis 1982; 126: 670.
266. Newman SP, Millar AB, Lennard-Jones TR, Morén F, Clarke SW. Improvement of pressurized aerosol deposition with Nebuhaler spacer device. Thorax 1984; 39: 935.
267. Barry PW, O'Callaghan C. Inhalation drug delivery from seven different inhalers. Thorax 1996; 51: 835.
268. Bisgaard H. Drug delivery from inhaler devices. Br Med J 1996; 313: 895.
269. O'Callaghan C, Barry P. Spacer devices in the treatment of asthma. Br Med J 1997; 314:1061.
270. Wildhaber JH, Devadason SG, Hayden MJ et al. Electrostatic charge on a plastic spacer device influences the delivery of salbutamol. Eur Respir J 1996; 9: 1943.
271. Woodcock A. Use of spacers with metered dose inhalers. Lancet 1997; 349: 446.
272. Prahl P, Jensen T. Decreased adreno-cortical suppression utilising the Nebuhaler for the inhalation of steroid aerosols. Clin Allergy 1987; 17: 393.
273. Brown PH, Blundell G, Greening AP, Crompton GK. Do large, spacer devices reduce the systemic effects of high dose inhaled corticosteroids? Thorax 1990; 45: 736.
274. Farrer M, Francis AJ, Pearce SJ. Morning serum cortisol concentrations after 2mg inhaled beclomethasone dipropionate in normal subjects: effect of a 750ml spacing device. Thorax 1990; 45: 740.
275. Brown PH, Matusiewicz SP, Shearing C, Greening AP, Crompton GK. Systemic effects of high dose inhaled steroids: comparison of beclomethasone dipropionate and budesonide in healthy subjects. Thorax 1993; 48: 967.
276. Toogood JH, Jennings B, Baskerville J, Newhouse M. Assessment of a device for reducing oropharyngeal complications during beclomethasone treatment of asthma. Am Rev Respir Dis 1981; 123: 113.
277. O'Reilly JF, Buchanan DR, Sudlow MF. Pressurised aerosol with conical spacer is an effective alternative to nebuliser in chronic stable asthma. Br Med J 1983; 286: 1548.
278. Prior JG, Nowell RV, Cochrane GM. Highdose inhaled terbutaline in the management of chronic severe asthma: comparison of wet nebulisation and tube-spacer delivery. Thorax 1982; 37: 300.
279. Crompton GK, Duncan J. Clinical assessment of a new breath-actuated inhaler. Practitioner 1989; 233: 268.
280. Newman SP, Weisz AWB, Talaee N, Clarke SW. Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax 1991; 46: 712.
281. Fergusson RJ, Lenny J, McHardy GJR, Crompton GK. The use of a new breathactuated inhaler by patients with severe airflow obstruction. Eur Respir J 1991; 4: 172.
282. Crompton GK. New inhalation devices. Eur Respir J 1988; 1: 679.
283. Anani A, Higgins AJ, Crompton GK. Breathactuated inhalers: comparison of terbutaline Turbohaler with salbutamol Rotahaler. Eur Respir J 1989; 2: 640.
284. Sininghe Damsté HEJ, Oostringaa P, Heeringa A. Clinical comparison of inhaled bindesoride administered via a pressurized metered close inhaler via Tuibuhaler® in patients with branchial asthma. Ein Respir J 1989: 2(Suppl 8): 861.
285. Pedersen S, Hansen OR, Fugsland G. Influence of inspiratory flow rate upon the effect of a Turbuhaler. Arch Dis Child 1990; 65: 308.
286. Dolovich M, Vanzieleghem M, Hidinger KG, Newhouse MT. Influence of inspiratory flow rate on the response to terbutaline sulphate inhaled via the Turbuhaler. Am Rev Respir Dis 1988; 137: A433.
287. Pedersen S. How to use a Rotahaler. Arch Dis Child 1986; 61: 11.
288. Thorsson L, Edsbäcker S, Conradson T-B. Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler p-MDI. Eur Respir J 1994; 7: 1839.
289. Selroos O, Halme M. Effect of a Volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler. Thorax 1991; 46: 891.
290. Hardy JG, Newman SP, Knoch M. Lung deposition from four nebulisers. Respir Med 1993; 87: 461.
291. Clay MM, Pavia D, Newman SP, Clarke SW. Factors influencing the size distribution of aerosols from jet nebulisers. Thorax 1983; 38:755.
292. Clay MM, Pavia D, Newman SP, Lennard-Jones T, Clarke SW. Assessment of jet nebulisers for lung aerosol therapy. Lancet 1983; ii: 592.
293. Newman SP, Pellow PGD, Clarke SW. The flow-pressure characteristics of compressors used for inhalation therapy. Eur J Respir Dis 1987; 71: 122.
294. Department of Health and Social Security. Health Equipment Information. An evaluation of powered nebulisers. London: HMSO, 1988.
295. Smith EC, Denyer J, Kendrick AH. Comparison of twenty three nebulizer/compressor combinations for domiciliary use. Eur Respir J 1995; 8: 1214.
296. British Thoracic Society. Current best practice for the use of nebulisers. Thorax 1997; 52 (Suppl 2): S1.
297. Committee on Safety of Medicines. CSM update: desensitizing vaccines. Br Med J 1986; 293: 948.
298. Warner JO, Kerr IW. Hyposensitization. Br Med J 1987; 294: 1179.
299. Lichtenstein LM, Valentine MD, Norman PS. Are-evaluation of immunotherapy for asthma. Am Rev Respir Dis 1984; 129: 657.
300. Sadan N, Rhyne MB, Mellits ED et al. Immunotherapy of pollenosis in children:an investigation of the immunological basis of clinical improvement. N Engl J Med 1969; 280: 623.
301. Sobotka AK, Valentine MD, Ishizaka K, Lichtenstein LM. Measurement of IgG blocking antibodies: development and application of an immunoassay. J Immunol 1976; 117: 84.
302. Frankland AW, Augustin R. Prophylaxis of summer hay fever and asthma: a controlled trial comparing crude grass poIlen extracts with the isolated main protein component. Lancet 1954; i: 1055.
303. Smith AP. Hyposensitization with Dermatophagoides pteronyssinus antigen: trial in asthma induced by house dust. Br Med J 1971; iv: 204.
304. Zeiger RS, Schatz M. Immunotherapy of atopic disorders. Med Clin North Am 1981; 65: 987.
305. Lichtenstein LM, Norman PJ, Winkenwerder WL. Asingle year of immunotherapy for ragweed hay fever. Ann Intern Med 1971; 75: 663.
306. Warner JO, Price JF, Soothill JF, Hey EN. Controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with asthma. Lancet 1978; ii: 912.
307. Wahn U, Siraganian RP. Efficacy and specificify of immunotherapy with laboratory animal allergen extracts. J Allergy Clin Immunol 1980; 65: 413.
308. Taylor WW, Ohman JL, Lowell FC. Immunotherapy in cat induced asthma. Double blind trial with evaluation of bronchial responses to cat allergen and histamine. J Allergy Clin Immunol 1978; 61: 283.
309. Bruce CA, Norman PS, Rosenthal RR, Lichtenstein LM. The role of ragweed pollen in autumnal asthma. J Allergy Clin Immunol 1977; 59: 449.
310. Forgacs P, Swan AD. Treatment of house dust allergy: a report from the research committee of the British Tuberculosis Association. Br Med J 1968; iii: 774.
311. Shale DJ, Faux JA, Lane DJ. Trial of ketoconazole in non-invasive pulmonary aspergillosis. Thorax 1987; 42: 26.
312. Gluck JC, Gluck PA. The effects of pregnancy on asthma: a prospective study. Ann Allergy 1976; 37: 164.
313. Stenius-Aarniala B, Piirialä P, Teramo K. Asthma and pregnancy: a prospective study of 198 pregnancies. Thorax 1988; 43: 12.